Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Neximmune Inc (NEXI)

Neximmune Inc (NEXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Neximmune Inc 9119 GAITHER ROAD GAITHERSBURG MD 20877 USA

www.neximmune.com Employees: 6 P: 301-825-9810

Description:

NexImmune Inc. is a clinical-stage biotechnology company. It engages in developing a novel approach to immunotherapy designed to employ the body's own T cells to generate a specific, potent and durable immune response that mimics natural biology. NexImmune Inc. is based in GAITHERSBURG, Md.

Key Statistics

Overview:

Market Capitalization, $K 324
Enterprise Value, $K -2,896
Shares Outstanding, K 1,395
Annual Sales, $ 0 K
Annual Net Income, $ -32,340 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -2,330 K
EBIT, $ -20,950 K
EBITDA, $ -19,930 K
60-Month Beta 1.68
% of Insider Shareholders 14.90%
% of Institutional Shareholders 9.85%
Float, K 1,187
% Float 85.10%
Short Volume Ratio 0.04

Growth:

1-Year Return -89.73%
3-Year Return -99.81%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.69 on 08/07/24
Next Earnings Date 12/27/24 [--]
Earnings Per Share ttm -18.29
EPS Growth vs. Prev Qtr 23.53%
EPS Growth vs. Prev Year 76.69%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-25 on 10/19/23

NEXI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -534.32%
Return-on-Assets % -213.72%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.54
Book Value/Share 0.51
Interest Coverage -1.36
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar